Shares of Kronos Worldwide Inc. (NYSE:KRO) dropped 3.9% during trading on Tuesday . The stock traded as low as $5.84 and last traded at $5.85, with a volume of 117,676 shares. The stock had previously closed at $6.09.

Separately, Zacks Investment Research raised Kronos Worldwide from a “hold” rating to a “buy” rating and set a $6.75 target price on the stock in a report on Tuesday, June 21st.

The company has a 50 day moving average of $5.60 and a 200-day moving average of $5.60. The company’s market cap is $674.42 million.

Kronos Worldwide (NYSE:KRO) last announced its quarterly earnings results on Friday, May 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.13) by $0.10. The business had revenue of $318.40 million for the quarter, compared to analysts’ expectations of $308.50 million. The firm’s quarterly revenue was down 12.8% on a year-over-year basis. During the same period last year, the firm earned $0.16 earnings per share. On average, equities research analysts predict that Kronos Worldwide Inc. will post $0.03 EPS for the current year.

An institutional investor recently raised its position in Kronos Worldwide stock. Dimensional Fund Advisors LP raised its position in Kronos Worldwide Inc. (NYSE:KRO) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,266,681 shares of the company’s stock after buying an additional 23,748 shares during the period. Dimensional Fund Advisors LP owned about 1.09% of Kronos Worldwide worth $7,144,000 at the end of the most recent quarter.

Kronos Worldwide, Inc is a producer and marketer of titanium dioxide (TiO2) pigments, a base industrial product that is used in a range of applications. The Company, along with its distributors and agents, sells and provides technical services for its products in approximately 100 countries with sales in Europe and North America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.